SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 25, 17:00
3566.65
42.2 (1.2%)
VOLUME 18,257
LIVE
NSE
Nov 25, 17:00
3573.20
51.2 (1.45%)
VOLUME 329,635
News on Dr Reddys Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Market maintains bull run, experts remain bullish  

4.29 pm | 24 Nov 2014 |  Source: CNBC-TV18

Market expert Ambareesh Baliga believes market will move up over the next four-five days or one week. According to him, the appetite for such market i...

Dr. Reddy's launches Docetaxel Injection USP

12.02 pm | 24 Nov 2014 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories has launched Docetaxel Injection USP 20 mg/ml and 50 mg/ml a therapeutic equivalent generic version of TAXOTERE in the US mark...

Dr Reddy's Laboratories launched over-the-counter Fexofenadine Hydrochloride

3.37 pm | 20 Nov 2014 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg/...

Sun Pharma, Lupin, Dr Reddy's preferred picks: Agarwal 

2.29 pm | 20 Nov 2014 |  Source: CNBC-TV18

According to Nitin Agrawal - Pharma Analyst at IDFC Securities, Sun Pharma, Lupin and Dr Reddy's labs are the preferred picks....

Here's why Sun, Lupin, DRL are still best pharma bets 

1.04 pm | 20 Nov 2014 |  Source: CNBC-TV18

Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the...

Buy Dr Reddy's, Aurobindo Pharma: Sudarshan Sukhani 

10.57 am | 20 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories and Aurobindo Pharma....

Do not short Nifty today; buy Wipro, ICICI Bank: Sukhani 

9.58 am | 20 Nov 2014 |  Source: CNBC-TV18

For Bank Nifty our stop loss was 17500, that it still holds so you hold on to your positions, says Sukhani....

Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte

2.55 pm | 18 Nov 2014 |  Source: Reuters

In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency'...

Sun, Merck to dissolve branded generics JV? 

7.17 pm | 14 Nov 2014 |  Source: CNBC-TV18

Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting...

Buy Dr Reddys Labs; target of Rs 3750: Angel Broking

2.12 pm | 14 Nov 2014 |  Source: Moneycontrol.com

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 3750 in its October 30, 2014 research repor...

Buy Dr Reedy's Labs 3500 call: VK Sharma 

10.45 am | 14 Nov 2014 |  Source: CNBC-TV18

VK Sharma of HDFC Securities recommends buying Dr Reddy's Laboratories 3500 Call....

Here are some stock picks from VK Sharma 

9.20 am | 14 Nov 2014 |  Source: CNBC-TV18

Watch the interview of VK Sharma of HDFC Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his reading and outlook on ma...

Go long on Nifty today; buy Rel Comm, Tata Power: Sukhani 

9.21 am | 12 Nov 2014 |  Source: CNBC-TV18

According to Sukhani, bank Nifty yesterday crossed the threshold of 17500 and so the Nifty could make an attempt to go to 8400 plus. Therefore, the bi...

Indian drugmakers see US sales hit by delay in new nods

8.34 am | 12 Nov 2014 |  Source: Reuters

India's USD 15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about productio...

Bullish on pharma; buy Lupin, Dr Reddys, Ipca: JM Financial 

12.16 pm | 10 Nov 2014 |  Source: CNBC-TV18

For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo....

Dr Reddy's, Endo get FDA approval to launch generic Valcyte

11.21 am | 07 Nov 2014 |  Source: Reuters

The US Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and US firm Endo Internationa...

Ranbaxy loses Valcyte exclusivity: An analysis 

10.14 am | 07 Nov 2014 |  Source: CNBC-TV18

Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche...

Ranbaxy, Sun Pharma fall 4-5%; analysts say DRL to benefit

10.04 am | 07 Nov 2014 |  Source: Moneycontrol.com

Brokerages are worried about the stocks and stress that approval of Sun Pharma-Ranbaxy deal will be key driver. They feel that this negative surprise ...

This is a buy & hold market for 12-15 months: Vibhav Kapoor 

9.52 am | 07 Nov 2014 |  Source: CNBC-TV18

Kapoor said the market was right now banking on hope and trying to discount FY16 numbers instead of FY15 numbers, be it macro or corporate earnings....

Ranbaxy may suffer loss of $250 mn on approval woes: Expert 

9.41 am | 07 Nov 2014 |  Source: CNBC-TV18

Surajit Pal, pharma analyst, Prabhudas Lilladher, expects Teva, Mylan, Sandoz and Dr Reddy’s Laboratories to benefit from this loss....

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.